Olema Pharmaceuticals's total assets for Q4 2024 were $450.98M, an increase of 95.93% from the previous quarter. OLMA total liabilities were $42.02M for the fiscal quarter, a 34.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.